Fund Holdings — Krensavage Asset Management, LLC

Total Portfolio Value:
$265.4K
Total Bought:
$12.1K
Total Sold:
$8.7K
Net Transaction:
+$3.4K
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Jazz Pharmaceuticals plc(JAZZ)167,816167,8160$40.4K$38.9K14.64%-$1.6K
Enanta Pharmaceuticals Inc2,866,1382,866,1380$41.8K$37.8K14.23%-$4.0K
United Therapeutics Corporation(UTHR)69,28266,282-3,000$37.5K$35.9K13.53%-$1.6K
BioMarin Pharmaceutical Inc.(BMRN)524,786524,7860$30.0K$31.5K11.86%+$1.5K
Abbott Laboratories200,000200,0000$18.1K$19.8K7.45%+$1.6K
Exelixis, Inc.(EXEL)370,693299,393-71,300$20.2K$17.5K6.59%-$2.7K
Ultragenyx Pharmaceutical Inc.(RARE)390,8791,140,867+749,988$13.1K$17.1K6.46%+$4.1K
Supernus Pharmaceuticals Inc280,681350,681+70,000$13.1K$15.1K5.69%+$2.0K
Sanofi(SNY)323,946333,946+10,000$13.8K$13.8K5.19%-$51
Embecta Corp1,135,3401,135,3400$3.7K$6.4K2.42%+$2.7K
Ardelyx Inc534,5231,815,492+1,280,969$2.7K$6.2K2.34%+$3.5K
BioNTech SE(BNTX)59,52359,5230$5.5K$5.9K2.20%+$312
Vanda Pharmaceuticals Inc1,180,3881,180,3880$7.2K$5.8K2.18%-$1.4K
GSK plc(GSK)96,72996,7290$5.1K$4.7K1.76%-$412
Biogen Inc.(BIIB)20,00020,0000$4.3K$4.5K1.70%+$197
Inmode Ltd120,942120,9420$1.8K$1.7K0.65%-$54
ANI Pharmaceuticals, Inc.(ANIP)013,000+13,000$0$9440.36%+$944
Acadia Pharmaceuticals Inc040,000+40,000$0$8060.30%+$806
Zoetis Inc.(ZTS)010,000+10,000$0$6980.26%+$698
Evolus Inc157,98557,985-100,000$1.1K$4640.17%-$632
Regeneron Pharmaceuticals, Inc.(REGN)6,0000-6,000$3.7K$0—-$3.7K
Page 1 of 1
Krensavage Asset Management, LLC — 13F Holdings — Q3 2026 | TickerTrail